Combined application of superficial chemical peeling and facial oxygen therapy in the treatment of papulopustular rosacea - a case study

  • Danijela Pecarski Academy of applied studies Belgrade, The College of Health Sciences
  • Milica Ignjatović Academy of applied studies Belgrade, The College of Health Sciences
  • Mila Filipović Academy of Applied Studies Belgrade, The College of Health Sciences

Abstract


Rosacea is a chronic, inflammatory skin disease that primarily affects the centrofacial region (cheeks, nose, chin, forehead) and eyes, characterized and diagnosed by recurrent flushing episodes, persistent erythema, inflammatory papules and/or pustules and telangiectasia. It cannot be cured, only "kept under control" by avoiding the causing factors, use of oral and/or topical drugs, appropriate cosmetic products and application of certain cosmetic treatments. Regarding the treatment of rosacea with pronounced inflammatory papules and pustules, the most common dermatological approach is the use of topical preparations with azelaic acid, while for the same indication in cosmetic procedures superficial azelaic chemical peeling is performed. The aim of this study was to evaluate the effectiveness of a new approach in the treatment of papulopustular rosacea - a combined application of superficial chemical peels with 20% azelaic acid and facial oxygen therapy. The client, 45 years old, female, diagnosed with papulopustular (PP) rosacea, diffuse erythema and PP lesions on the cheeks, forehead and chin, without pharmacological therapy, underwent superficial chemical peel treatment with 20% azelaic acid. The solution was applied to the PP lesions region, neutralized and hydraporation was performed with oxygen jet and hyaluronic acid serum, for 10 minutes. Seven days after the treatment, there were a reduction of inflammatory papules and pustules of the centrofacial region, reduction of erythema and improvement of the skin appearance. Skin condition, with adequate skin care advice, remained unchanged even after three months. Mentioned approach could be successfully in the treatment of mild to moderate papulopustular rosacea.

References

Del Rosso JQ, Tanghetti E, Webster G, Gold LS, Thiboutot D, Gallo RL. Update on the management of rosacea from the American Acne & Rosacea Society (AARS). J. Clin. Aesthet. Dermatol. 2020; 13(6 Suppl): S17-S24.

Dall’Oglio F, Tedeschi A, Lacarrubba F, Fabbrocini G, Skroza N, Chiodini P, Micali G. A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial. J Cosmet. Dermatol. 2021; 20: 28-31.

Published
2022/10/18
Section
Poster presentations session Pharmaceutical technology and cosmetology